To be looked into

2016-05-22

$Cancer Genetics Inc.(CGIX)$ 临床测序，药物开发。动因1，合作，药物开发或诊断试剂方法等；2，FDA对于商业测序服务的约束政策有无放松，23&me可参照；3，财报，2016一二季度均推高；

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

天道酬勤股道至简
2016-07-08
天道酬勤股道至简
布局就等他

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":15749,"tweetId":"15749","gmtCreate":1463894277921,"gmtModify":1704871406881,"author":{"id":81450366323748,"idStr":"81450366323748","authorId":81450366323748,"authorIdStr":"81450366323748","name":"Remy","avatar":"https://static.laohu8.com/aa475fe7393c8d11e70c3a5f906a05d8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":51,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"To be looked into","extraTitle":"","html":"<html><head></head><body><p>$Cancer Genetics Inc.(CGIX)$ 临床测序，药物开发。动因1，合作，药物开发或诊断试剂方法等；2，FDA对于商业测序服务的约束政策有无放松，23&amp;me可参照；3，财报，2016一二季度均推高；</p></body></html>","htmlText":"<html><head></head><body><p>$Cancer Genetics Inc.(CGIX)$ 临床测序，药物开发。动因1，合作，药物开发或诊断试剂方法等；2，FDA对于商业测序服务的约束政策有无放松，23&amp;me可参照；3，财报，2016一二季度均推高；</p></body></html>","text":"$Cancer Genetics Inc.(CGIX)$ 临床测序，药物开发。动因1，合作，药物开发或诊断试剂方法等；2，FDA对于商业测序服务的约束政策有无放松，23&me可参照；3，财报，2016一二季度均推高；","highlighted":1,"essential":1,"paper":2,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/15749","repostId":0,"isVote":1,"tweetType":1,"viewCount":2071,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VYNT"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":158,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":155626,"commentId":"155626","gmtCreate":1467990220478,"gmtModify":1467990220478,"authorId":3335149883240,"author":{"id":3335149883240,"idStr":"3335149883240","authorId":3335149883240,"name":"天道酬勤股道至简","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":15749,"objectIdStr":"15749","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"布局 就等他","text":"布局 就等他","html":"布局 就等他","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/15749"}